BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 34732125)

  • 1. Identification of DNA methylation-driven genes and construction of a nomogram to predict overall survival in pancreatic cancer.
    Deng GC; Sun DC; Zhou Q; Lv Y; Yan H; Han QL; Dai GH
    BMC Genomics; 2021 Nov; 22(1):791. PubMed ID: 34732125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
    Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
    Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
    [No Abstract]   [Full Text] [Related]  

  • 3. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Validation of Constructing the Prognostic Model With Four DNA Methylation-Driven Genes in Pancreatic Cancer.
    Chen G; Long J; Zhu R; Yang G; Qiu J; Zhao F; Liu Y; Tao J; Zhang T; Zhao Y
    Front Cell Dev Biol; 2021; 9():709669. PubMed ID: 35087823
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
    Wang H; Wei C; Pan P; Yuan F; Cheng J
    Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma.
    He D; Liao S; Cai L; Huang W; Xie X; You M
    BMC Cancer; 2021 May; 21(1):599. PubMed ID: 34034705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
    Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
    J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel tp53-associated nomogram to predict the overall survival in patients with pancreatic cancer.
    Liu X; Chen B; Chen J; Sun S
    BMC Cancer; 2021 Mar; 21(1):335. PubMed ID: 33789615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.
    Li X; Yin F; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J
    Cancer Med; 2021 Jan; 10(2):693-708. PubMed ID: 33350104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomogram Predicts Risk and Prognostic Factors for Bone Metastasis of Pancreatic Cancer: A Population-Based Analysis.
    Zhang W; Ji L; Wang X; Zhu S; Luo J; Zhang Y; Tong Y; Feng F; Kang Y; Bi Q
    Front Endocrinol (Lausanne); 2021; 12():752176. PubMed ID: 35356148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
    Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
    Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A methylomics-correlated nomogram predicts the recurrence free survival risk of kidney renal clear cell carcinoma.
    Zhu X; Ma X; Wu C
    Math Biosci Eng; 2021 Oct; 18(6):8559-8576. PubMed ID: 34814313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study.
    Shi H; Chen Z; Dong S; He R; Du Y; Qin Z; Zhou W
    BMC Gastroenterol; 2022 Jun; 22(1):279. PubMed ID: 35658912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.
    Wang Y; Zhang L; Wang B; Cheng Y
    Biomed Res Int; 2021; 2021():6699131. PubMed ID: 34337046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A methylomics-associated nomogram predicts the overall survival risk of stage III to IV ovarian cancer.
    Wei X; Hu W; Mao K
    Medicine (Baltimore); 2023 Feb; 102(5):e32766. PubMed ID: 36749233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.
    Wang X; Zhou B; Xia Y; Zuo J; Liu Y; Bi X; Luo X; Zhang C
    BMC Cancer; 2021 Jul; 21(1):801. PubMed ID: 34247575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma.
    Zhang Z; Lin E; Zhuang H; Xie L; Feng X; Liu J; Yu Y
    Cancer Cell Int; 2020; 20():27. PubMed ID: 32002016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W; Liu J; Zhao H
    Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
    Wu M; Li X; Zhang T; Liu Z; Zhao Y
    Front Oncol; 2019; 9():996. PubMed ID: 31612115
    [No Abstract]   [Full Text] [Related]  

  • 20. Nomogram Based on microRNA Signature Contributes to Improve Survival Prediction of Clear Cell Renal Cell Carcinoma.
    Zhao E; Bai X
    Biomed Res Int; 2020; 2020():7434737. PubMed ID: 32280701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.